Presentation is loading. Please wait.

Presentation is loading. Please wait.

How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James.

Published byΣτράτων Αλαβάνος Modified over 5 years ago

Similar presentations

Presentation on theme: "How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James."— Presentation transcript:

1 How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James W.F. Catto  European Urology Oncology  DOI: /j.euo Copyright © 2019 The Author(s) Terms and Conditions

2 Fig. 1 Correlation of disease progression and mortality with duration of follow-up. MA = meta-analysis. Adapted from Kulkarni et al [15]. European Urology Oncology DOI: ( /j.euo ) Copyright © 2019 The Author(s) Terms and Conditions

Download ppt "How to Treat a Patient with T1 High-grade Disease and No Tumour on Repeat Transurethral Resection of the Bladder?  Shahrokh Shariat, Paolo Gontero, James."

Similar presentations

Volume 64, Issue 3, Pages (September 2013)

Volume 64, Issue 3, Pages (September 2013)
Volume 58, Issue 2, Pages (August 2010)

Volume 58, Issue 2, Pages (August 2010)
Volume 55, Issue 3, Pages (March 2009)

Volume 55, Issue 3, Pages (March 2009)
The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks  Marcus G.

The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks  Marcus G.
Epidemiology and Risk Factors of Urothelial Bladder Cancer

Epidemiology and Risk Factors of Urothelial Bladder Cancer
The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients 
Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer  Francesco Cantiello, Giorgio.

Systemic Inflammatory Markers and Oncologic Outcomes in Patients with High-risk Non–muscle-invasive Urothelial Bladder Cancer  Francesco Cantiello, Giorgio.
European Urology Oncology

European Urology Oncology
Volume 49, Issue 2, Pages (February 2006)

Volume 49, Issue 2, Pages (February 2006)
Volume 61, Issue 5, Pages (May 2012)

Volume 61, Issue 5, Pages (May 2012)
Volume 69, Issue 1, Pages (January 2016)

Volume 69, Issue 1, Pages (January 2016)
Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database 

Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database 
Volume 51, Issue 3, Pages (March 2007)

Volume 51, Issue 3, Pages (March 2007)
Volume 69, Issue 2, Pages (February 2016)

Volume 69, Issue 2, Pages (February 2016)
Volume 60, Issue 1, Pages (July 2011)

Volume 60, Issue 1, Pages (July 2011)
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance

Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis  Sebastiano Nazzani, Felix Preisser, Marco Bandini, Michele Marchioni,

Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis  Sebastiano Nazzani, Felix Preisser, Marco Bandini, Michele Marchioni,
Re: Marcus G. Cumberbatch, Matteo Rota, James W. F

Re: Marcus G. Cumberbatch, Matteo Rota, James W. F
Volume 63, Issue 4, Pages (April 2013)

Volume 63, Issue 4, Pages (April 2013)
European Urology Oncology

European Urology Oncology

Similar presentations

Ads by Google